methyl 2-(1-methyl-1H-2-phenylthioimidazol-5-yl)glyoxylate | 244086-68-8

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: methyl 2-(1-methyl-1H-2-phenylthioimidazol-5-yl)glyoxylate
• 英文别名: Methyl 2-(3-methyl-2-phenylsulfanylimidazol-4-yl)-2-oxoacetate
• CAS: 244086-68-8
• 化学式: C₁₃H₁₂N₂O₃S
• 分子量: 276.316
• InChiKey: ZJNJWINXUGIUAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  86.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 2-(1-methyl-1H-2-phenylthioimidazol-5-yl)glyoxylate 在 4 A molecular sieve 、 potassium tert-butylate 、 镍 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 49.0h， 生成 didemnimide C
  参考文献：
  名称：

  Improved Synthesis of Isogranulatimide, a G2 Checkpoint Inhibitor. Syntheses of Didemnimide C, Isodidemnimide A, Neodidemnimide A, 17-Methylgranulatimide, and Isogranulatimides A−C

  摘要：

  A concise, improved synthesis of isogranulatimide (6), a naturally occurring substance with G2 checkpoint inhibition activity, is described. Also reported are the syntheses of didemnimide C (18), isodidemnimide A (24), neodidemnimide A (36), 17-methylgranulatimide (9), and isogranulatimides A (10), B (11), and C (12). Compounds 9-12, congeners of isogranulatimide (6), are now available for biological evaluation.

  DOI：

  10.1021/jo9914723
• 作为产物：
  描述：

  草酸二甲酯 、 1-methyl-2-phenylsulfanyl-1H-imidazole 在 lithium diisopropyl amide 作用下， 以 乙二醇二甲醚 、 乙醚 、 正己烷 为溶剂， 反应 4.25h， 以41%的产率得到methyl 2-(1-methyl-1H-2-phenylthioimidazol-5-yl)glyoxylate
  参考文献：
  名称：

  Improved Synthesis of Isogranulatimide, a G2 Checkpoint Inhibitor. Syntheses of Didemnimide C, Isodidemnimide A, Neodidemnimide A, 17-Methylgranulatimide, and Isogranulatimides A−C

  摘要：

  A concise, improved synthesis of isogranulatimide (6), a naturally occurring substance with G2 checkpoint inhibition activity, is described. Also reported are the syntheses of didemnimide C (18), isodidemnimide A (24), neodidemnimide A (36), 17-methylgranulatimide (9), and isogranulatimides A (10), B (11), and C (12). Compounds 9-12, congeners of isogranulatimide (6), are now available for biological evaluation.

  DOI：

  10.1021/jo9914723

文献信息

• GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT
  申请人：THE UNIVERSITY OF BRITISH COLUMBIA

  公开号：EP1070068A1

  公开（公告）日：2001-01-24
• US6291447B1
  申请人：——

  公开号：US6291447B1

  公开（公告）日：2001-09-18
• [EN] GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT<br/>[FR] DERIVES DE GRANULATIMIDE UTILISES DANS LE TRAITEMENT DU CANCER
  申请人：THE UNIVERSITY OF BRITISH COLUMBIA

  公开号：WO1999047522A1

  公开（公告）日：1999-09-23

  (EN) Novel granulatimide compounds and pharmaceutical formulations thereof are provided. Compounds of this invention have general formula (I) or (II) wherein are independently R or Z as defined below, or in combination F and F' is Ar1 as defined below; Ar1 is a monocyclic, bicyclic or tricyclic, fully or partially aromatic system containing five or six membered carbocyclic or, oxygen, nitrogen or sulphur containing heterocyclic rings, optionally substituted with R or Z; W is selected from the group consisting of formula (i); (ii) or (iii), wherein the structures are as described in: (i), (ii) and (iii). R and Z are optional substituents as defined in the application.(FR) L'invention concerne de nouveaux composés de granulatimide et des formulations pharmaceutiques de ceux-ci. Les composés de l'invention sont représentés par la formule (I) ou (II). Dans cette formule, F et F' représentent indépendamment R ou Z tels que définis ci-dessous, ou F et F' en combinaison représentent Ar1 tel que défini ci-dessous; Ar1 représente un système monocyclique, bicyclique ou tricyclique partiellement ou totalement aromatique, contenant des noyaux carbocycliques à cinq ou six éléments, ou de l'oxygène, de l'azote ou du soufre comprenant des noyaux hétérocycliques, éventuellement substitués par R ou Z; W est sélectionné dans le groupe constitué par les formules (i), (ii) ou (iii), les structures étant telles que ci-dessous.
• Improved Synthesis of Isogranulatimide, a G2 Checkpoint Inhibitor. Syntheses of Didemnimide C, Isodidemnimide A, Neodidemnimide A, 17-Methylgranulatimide, and Isogranulatimides A−C
  作者：Edward Piers、Robert Britton、Raymond J. Andersen

  DOI：10.1021/jo9914723

  日期：2000.1.1

  A concise, improved synthesis of isogranulatimide (6), a naturally occurring substance with G2 checkpoint inhibition activity, is described. Also reported are the syntheses of didemnimide C (18), isodidemnimide A (24), neodidemnimide A (36), 17-methylgranulatimide (9), and isogranulatimides A (10), B (11), and C (12). Compounds 9-12, congeners of isogranulatimide (6), are now available for biological evaluation.